Table 4.

Clinical characteristics of 39 systemic lupus erythematosus (SLE) patients with flare and after resolution of flare. Data are median ± SD unless otherwise indicated.

CharacteristicSLE with FlareResolution of Flarep
Malar rash, n (%)9 (23.1)4 (10.3)0.224
Serositis, n (%)3 (7.7)0 (0)0.24
Oral ulcer, n (%)10 (25.6)0 (0)0.001
Arthritis, n (%)25 (64.1)1 (2.6)< 0.001
Photosensitivity, n (%)2 (5.1)0 (0)0.494
Alopecia, n (%)11 (28.2)2 (5.1)0.013
Renal disease, n (%)8 (20.5)2 (5.1)0.087
Neurologic disorder, n (%)1 (2.6)0 (0)1.0
Anti-dsDNA, IU/ml38.82 ± 42.5822.05 ± 30.300.035
Hemoglobin, g/dl11.75 ± 1.5712.34 ± 1.300.107
Leukocytes, μl6375 ± 42715748 ± 25170.952
Lymphocytes, μl1134 ± 7521305 ± 7540.131
Platelets, × 103/μl237.36 ± 85.51256.54 ± 72.050.322
Complement 3, mg/dl60.38 ± 25.2388.57 ± 26.61< 0.001
ESR, mm/h25.21 ± 20.1215.92 ± 17.220.017
SLEDAI score10.74 ± 5.112.1 ± 1.83< 0.001
CRP, mg/dl0.06 (0.03, 0.15)0.05 (0.02, 0.13)0.333
S100A8/A9, μg/ml1.07 (0.49, 3.05)0.86 (0.4, 4.01)0.78
Procalcitonin, ng/ml0 (0, 0)0 (0, 0)1.0
  • ESR: erythrocyte sedimentation rate; SLEDAI: Systemic Lupus Erythematosus Disease Activity Index; CRP: C-reactive protein. CRP, S100A8/A9, and procalcitonin are expressed as median (interquartile range). Other data are number (%) or mean ± SD.